rs5030730
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004006.3(DMD):c.3940C>T(p.Arg1314Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R1314R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004006.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.3940C>T | p.Arg1314Ter | stop_gained | 29/79 | ENST00000357033.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.3940C>T | p.Arg1314Ter | stop_gained | 29/79 | 1 | NM_004006.3 | P4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:6
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 10, 2018 | The variant creates a premature nonsense codon, and is therefore predicted to significantly disrupt the protein structure. Found in at least one symptomatic patient, and not found in general population data. - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2019 | Reported in ClinVar as pathogenic (ClinVar Variant ID# 11283; Landrum et al., 2016); Not observed in large population cohorts (Lek et al., 2016); Immunohistochemical analysis of muscle biopsy showed reduced dystrophin for antibodies to the N and C termini, but showed absent dystrophin for antibodies that corresponded to exon 29 (Ginjaar et al., 2000). RNA analysis of different probands with this variant revealed up to 3 transcripts: R1314X in exon 29, and 2 alternatively spliced versions missing either exon 29 or exons 28 and 29, which both bypass the nonsense variant (Ginjaar et al., 2000; Deburgrave et al., 2007). Furthermore, the truncated protein was visible by Western blot (Ginjaar et al., 2000); Other nonsense variants in DMD have been reported in the Human Gene Mutation Database in association with dystrophimopathies (Stenson et al., 2014); Based on the understanding of this genetic alteration, it may be amenable to nonsense read-through therapy that is currently available or in clinical trial; This variant is associated with the following publications: (PMID: 28116794, 17041906, 25525159, 11039581, 16770791, 19959795, 25972034, 30833962, 29604111, 29581631) - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 08, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 22, 2017 | - - |
Duchenne muscular dystrophy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Feb 24, 2021 | Studies have shown that this variant is associated with skipping of exon 29 but is expected to preserve the integrity of the reading frame (PMID: 11039581, 17041906, 24292997). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in several individuals and families affected with Becker muscular dystrophy (PMID: 11039581, 17041906, 19959795, 24292997, 29581631). ClinVar contains an entry for this variant (Variation ID: 11283). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg1314*) in the DMD gene. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. - |
Pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
Qualitative or quantitative defects of dystrophin Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 28, 2023 | Variant summary: DMD c.3940C>T (p.Arg1314X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Variants downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 182875 control chromosomes (gnomAD). c.3940C>T has been reported in the literature in multiple hemizygous males affected with Becker Muscular Dystrophy, dilated cardiomyopathy, and elevated serum creatine kinase levels (e.g., Franz_2000, Ginjaar_2000, Deburgrave_2007, Torella_2010), and the variant has been shown to segregate with disease in related individuals. These data indicate that the variant is very likely to be associated with disease. Several publications report experimental evidence evaluating an impact on protein, finding that alternative exon skipping restored the open reading frame in a portion of transcripts in patient tissue, however, the level of exon skipping varied across tissues and between patients, correlating with disease severity and phenotypic outcomes (e.g., Franz_2000, Ginjaar_2000, Deburgrave_2007). The following publications have been ascertained in the context of this evaluation (PMID: 17041906, 10832829, 11039581, 19959795). Five submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Becker muscular dystrophy Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2000 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at